HIGHLIGHTS
- who: Simon M. Y. Lee from the State Key Laboratory of Quality Research Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Cambridge, United Kingdom have published the research work: BHDPC Is a Novel Neuroprotectant That Provides Anti-neuroinflammatory and Neuroprotective Effects by Inactivating NF-u03baB and Activating PKA/CREB, in the Journal: (JOURNAL)
- what: The authors showed for the first time that the novel neuroprotectant, BHDPC could inhibit neuroinflammatory responses in LPS-activated BV-2 microglia cells. The authors also used HT22 hippocampal neurons and the BV-2 microglia co-culture system to . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.